OncoGenex Pharmaceuticals Inc (NASDAQ:OGXI)

2.15
Delayed Data
As of Mar 31
 0.00 / 0.00%
Today’s Change
1.92
Today|||52-Week Range
12.09
-6.11%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2011

2012

2013

2014
Operating ActivitiesNet Income / Starting Line-14.7M-21.1M-31.8M--
 
 
 
 
Depreciation75.0K100.0K227.0K--
 
 
 
 
Total Other Cash Flow-6.2M-4.1M-3.0M--
 
 
 
 
Funds From Operations-20.8M-25.1M-34.7M--
 
 
 
 
Funds From/For Other Operating Expenses-535.0K18.4M1.3M--
 
 
 
 
Net Cash Flow - Operating Activities-20.3M-43.5M-35.9M--
 
 
 
 
 
InvestingIncrease In Investments-75.1M-110.4M-31.7M--
 
 
 
 
Decrease In Investments100.3M89.5M64.4M--
 
 
 
 
Capital Expenditures-79.0K-291.0K-253.0K--
 
 
 
 
Net Cash Flow Investing25.1M-21.2M32.4M--
 
 
 
 
 
FinancingShort Term Borrowings0.000.000.00----
Long Term Borrowings0.000.000.00----
Long Term Debt Reduction0.000.000.00----
Net Proceeds Stock Sale219.0K54.2M10.0K--
 
 
 
 
Common Preferred Redeemed0.000.000.00----
Common Dividends0.000.000.00----
Cash Dividends Paid - Total0.000.000.00----
Other Sources - Financing0.000.000.00----
Other Uses - Financing0.000.000.00----
Net Cash Flow - Financing219.0K54.2M10.0K--
 
 
 
 
 
Exchange RateEffect of Exchange Rate on Cash-40.0K0.009.0K--
 
 
 
 
Net Change In Cash5.0M-10.4M-3.5M0.00
 
 
 
 

To view my watchlist

Not a member yet?

Sign up now for a free account